Whenever the secondary market booms, come the promoters of companies with their IPos, enthusiastically supported by pink papers. Investors are lured in such a way with the euphoric feelings and intense excitement that, even after having burnt their fingers in the past, still they come again believing the party will continue ad infinitum.
One of the first IPO boom recorded in the history of the stock market was in USA, way back in 1825.
Anecdotal evidence suggests that a man had been squeezed to death in the stampede to buy shares in the new Bank of Southwark. The higher mortals hired thugs to punch their way to the front of the line. All this ordeal suffered only to see the value of the shares purchased losing roughly by a quarter of their value in next few years.
Extraordinary Year for Primary Market
The current mad rush for IPO in Indian market and especially in last one month of FY18 is nowhere near to above incidence nor it is comparable, however, the result is likely to remain the same. Many of the current issues are likely to lose some part of their value in coming years. This is even visible now when 5 out of 8 issues hitting in the month of March are trading below their issue price. When we extend this for the entire FY18, the picture does not get very rosy. Out of 37 companies getting listed in NSE in FY18, 16 companies have given a negative return compared to its issue price. This is against the backdrop that broader and Frontline equity indices have given a return of 15% and 12%, respectively (See table: Performance of IPOs of FY18).
Coming back to a number of IPOs in FY18. month-wise analysis of data shows that last month of FY18 remained fairly active and every week two issues hit the primary market raising to the tune of almost `15000 crore. The reason for such hyperactivity was because month of February remained quite subdued in terms of IPOs and implementation of long term capital gain tax from FY19 (for detail see the box: Reasons for higher IPOs).
This story is from the April 2018 edition of Indian Economy & Market.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 2018 edition of Indian Economy & Market.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
WORLD DEVELOPMENT REPORT 2024 THE MIDDLE-INCOME TRAP
A World Bank report titled 'World Development Report 2024: The Middle-Income Trap' indicates that India may take up to 75 years to attain just a quarter of the United States' per capita income. The insights in the report provides a useful reality check for India's ambitious goals, such as becoming a developed economy by 2047 or reaching a $5 trillion economy within the next three years.
IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”
Sudarshan Pharma Industries Ltd., led by its promoters, Mr. Hemal V. Mehta, a chemical engineer, and Mr. Sachin V. Mehta, has established a strong foundation in specialty chemicals and bulk drugs. Their relentless enthusiasm is visible when they speak. Indian Economy & Market reached out, to piece together the company's achievements and new initiatives in detail.
Sudarshan Pharma Industries Ltd. A MULTIBAGGER IN MAKING
Sudarshan Pharma Industries Ltd. operates across various sectors in both the pharmaceutical and chemical industries, with a focus on specialty chemicals and intermediates, which find applications in Indian Le pharmaceuticals, paints, food products, and adhesives.
MUTUAL FUND LITE OR MF LIT PROMISING PROGRESS FOR INVESTORS
The SEBI has streamlined rules for passively managed schemes to have the impact of letting more players in the mutual fund ecosystem and offering diversified, low-risk investment options to retail investors. It would increase market liquidity and attract participation from old as well as new Asset Management Companies (AMCs). Shivanand Pandit feels that MF Lite is going to democratize investment opportunities in the Indian financial market.
GLOBALISM, FREEDOM & DEMOCRACY DO NOT MIX
The world today is packed with wealthy institutions and individuals that stand in revolt against the ideas of freedom and democracy. They do not like the idea of geographically constrained states with zones of juridical power.
BRICS Member States Ready to Dethrone Dollar
AS the US weaponises the dollar in the Russian and Iranian sanctions, there is increasing desire by other developing countries to seek alternative currencies for trade, investment, and reserves, as well as developing alternative multilateral clearance systems outside of SWIFT.
7 BEST PHARMA COMPANIES
The pharmaceutical industry in India is expected to reach $65 Bn by end of 2024 and to $130 Bn by 2030. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. While Nifty's performance has been lackluster over the past month, several pharmaceutical stocks have shown resilience.
NEW INVESTMENT PRODUCT CATEGORY IS SEBI'S LATEST MOVE COMMENDABLE?
The Securities and Exchange Board of India (SEBI) has introduced a consultation paper proposing a new investment product category aimed at addressing a specific market need. This proposed asset class would offer investment options that sit between mutual funds (MFS) and PMS, filling a gap and providing greater flexibility in portfolio management. The new investment vehicle is designed for investors who are prepared to take on riskier market positions but find PMS schemes or AIFs out of reach. SEBI after reviewing the feedback and finalizing the regulations through stakeholder discussions, may issue the final regulations.
DECODING THE CHINA MYTH
Myths die hard. Among these is the great myth that China's poised to take over the world. Here, James Rickards debunks that myth.
What Is In Store For The Indian Economy?
Until the 2014 Lok Sabha elections, when the Bharatiya Janata Party secured 282 seats and Narendra Modi ascended to power, India experienced 21 years of coalition governments. A decade later, the BJP holds 240 seats in the Lok Sabha, and India is once again governed by a coalition. Fitch has indicated that coalition politics and a weakened mandate for the NDA could hinder the passage of ambitious reform legislation. It raises the question: Do coalition governments impede the economic reform agenda?
